Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Messenger | 14 | 2025 | 1574 | 2.050 |
Why?
|
| RNA Precursors | 3 | 2024 | 78 | 1.440 |
Why?
|
| Sequence Analysis, RNA | 9 | 2024 | 180 | 1.400 |
Why?
|
| Transcription Initiation Site | 3 | 2025 | 47 | 1.250 |
Why?
|
| RNA Splicing | 4 | 2025 | 170 | 1.250 |
Why?
|
| Gene Expression Regulation | 13 | 2025 | 1630 | 1.240 |
Why?
|
| Transcription, Genetic | 8 | 2025 | 907 | 1.230 |
Why?
|
| Quantitative Trait Loci | 9 | 2017 | 81 | 1.080 |
Why?
|
| Alternative Splicing | 4 | 2022 | 138 | 0.980 |
Why?
|
| Transcription Initiation, Genetic | 1 | 2025 | 3 | 0.930 |
Why?
|
| Transcription Termination, Genetic | 1 | 2025 | 4 | 0.930 |
Why?
|
| DNA Methylation | 5 | 2015 | 302 | 0.920 |
Why?
|
| Chromatin | 8 | 2025 | 641 | 0.810 |
Why?
|
| RNA, Long Noncoding | 2 | 2022 | 171 | 0.780 |
Why?
|
| Introns | 4 | 2022 | 114 | 0.760 |
Why?
|
| Transcriptome | 2 | 2022 | 399 | 0.660 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2018 | 103 | 0.660 |
Why?
|
| RNA Polymerase II | 3 | 2025 | 86 | 0.650 |
Why?
|
| Islets of Langerhans | 1 | 2022 | 286 | 0.640 |
Why?
|
| Gene Expression | 3 | 2012 | 852 | 0.630 |
Why?
|
| Genetic Variation | 6 | 2017 | 394 | 0.620 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2014 | 103 | 0.510 |
Why?
|
| RNA Stability | 3 | 2022 | 104 | 0.500 |
Why?
|
| Genome, Human | 6 | 2015 | 237 | 0.470 |
Why?
|
| Pan troglodytes | 3 | 2014 | 33 | 0.470 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 731 | 0.440 |
Why?
|
| Exons | 5 | 2024 | 208 | 0.440 |
Why?
|
| Models, Genetic | 2 | 2016 | 266 | 0.420 |
Why?
|
| Gene Expression Profiling | 9 | 2025 | 794 | 0.420 |
Why?
|
| Drosophila | 1 | 2017 | 480 | 0.420 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 559 | 0.400 |
Why?
|
| Humans | 36 | 2025 | 65140 | 0.320 |
Why?
|
| Genome-Wide Association Study | 6 | 2015 | 361 | 0.300 |
Why?
|
| Polyadenylation | 3 | 2025 | 51 | 0.280 |
Why?
|
| Computational Biology | 3 | 2024 | 367 | 0.270 |
Why?
|
| Environment | 2 | 2018 | 125 | 0.260 |
Why?
|
| RNA, Small Interfering | 3 | 2025 | 981 | 0.260 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2024 | 312 | 0.240 |
Why?
|
| Models, Theoretical | 2 | 2018 | 274 | 0.240 |
Why?
|
| Animals | 11 | 2025 | 21345 | 0.240 |
Why?
|
| RNA Isoforms | 1 | 2025 | 6 | 0.230 |
Why?
|
| Interphase | 1 | 2025 | 68 | 0.230 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2025 | 182 | 0.220 |
Why?
|
| Caspase 8 | 1 | 2025 | 66 | 0.210 |
Why?
|
| Pyroptosis | 1 | 2025 | 38 | 0.210 |
Why?
|
| Chromosomes | 1 | 2025 | 139 | 0.210 |
Why?
|
| Cytoplasm | 1 | 2025 | 283 | 0.210 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2025 | 84 | 0.210 |
Why?
|
| Transgenes | 1 | 2025 | 204 | 0.210 |
Why?
|
| Protein Isoforms | 2 | 2022 | 201 | 0.210 |
Why?
|
| Mitosis | 1 | 2025 | 222 | 0.210 |
Why?
|
| Deoxyribonuclease I | 3 | 2012 | 41 | 0.200 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2022 | 153 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 5 | 2025 | 687 | 0.200 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2022 | 4 | 0.190 |
Why?
|
| Cell Line | 8 | 2017 | 2024 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2015 | 509 | 0.190 |
Why?
|
| Friedreich Ataxia | 1 | 2022 | 8 | 0.190 |
Why?
|
| Chromosome Mapping | 2 | 2015 | 296 | 0.190 |
Why?
|
| Protein Biosynthesis | 1 | 2025 | 333 | 0.190 |
Why?
|
| RNA Splice Sites | 3 | 2018 | 22 | 0.180 |
Why?
|
| Alleles | 3 | 2014 | 453 | 0.180 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 10 | 0.180 |
Why?
|
| Tyrosinemias | 1 | 2021 | 20 | 0.170 |
Why?
|
| Recombinational DNA Repair | 1 | 2021 | 29 | 0.170 |
Why?
|
| DNA, Mitochondrial | 3 | 2011 | 86 | 0.170 |
Why?
|
| Transcription Factors | 6 | 2017 | 1556 | 0.170 |
Why?
|
| Cell Proliferation | 2 | 2022 | 1038 | 0.170 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 447 | 0.170 |
Why?
|
| Inflammation | 2 | 2025 | 1192 | 0.160 |
Why?
|
| Dendritic Cells | 2 | 2015 | 531 | 0.160 |
Why?
|
| Base Sequence | 2 | 2022 | 1332 | 0.160 |
Why?
|
| Apoptosis | 1 | 2025 | 1098 | 0.160 |
Why?
|
| Huntingtin Protein | 1 | 2019 | 147 | 0.140 |
Why?
|
| Gene Ontology | 1 | 2018 | 38 | 0.140 |
Why?
|
| Heat-Shock Response | 1 | 2018 | 38 | 0.140 |
Why?
|
| Mutation | 3 | 2019 | 2661 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 4 | 2012 | 414 | 0.130 |
Why?
|
| Central Nervous System | 1 | 2019 | 200 | 0.130 |
Why?
|
| Gene Editing | 1 | 2021 | 328 | 0.130 |
Why?
|
| Huntington Disease | 1 | 2018 | 160 | 0.120 |
Why?
|
| Species Specificity | 2 | 2014 | 339 | 0.120 |
Why?
|
| Phosphorylation | 1 | 2018 | 962 | 0.120 |
Why?
|
| RNA Interference | 2 | 2025 | 643 | 0.120 |
Why?
|
| Genetic Vectors | 1 | 2021 | 918 | 0.110 |
Why?
|
| Dependovirus | 1 | 2021 | 751 | 0.110 |
Why?
|
| HapMap Project | 2 | 2012 | 5 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2015 | 150 | 0.100 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 1225 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 1698 | 0.100 |
Why?
|
| Phenotype | 2 | 2015 | 1233 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 279 | 0.100 |
Why?
|
| Proteins | 1 | 2018 | 764 | 0.090 |
Why?
|
| RNA | 1 | 2016 | 426 | 0.090 |
Why?
|
| Pseudogenes | 1 | 2012 | 12 | 0.090 |
Why?
|
| DNA, Intergenic | 1 | 2012 | 24 | 0.090 |
Why?
|
| Neurons | 1 | 2018 | 933 | 0.090 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2012 | 38 | 0.090 |
Why?
|
| Gene Dosage | 1 | 2012 | 72 | 0.090 |
Why?
|
| DNA Footprinting | 1 | 2012 | 18 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2012 | 6 | 0.090 |
Why?
|
| Tuberculosis | 2 | 2015 | 309 | 0.090 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2012 | 9 | 0.090 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 71 | 0.090 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2025 | 161 | 0.090 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 350 | 0.090 |
Why?
|
| Genetics, Population | 2 | 2009 | 45 | 0.090 |
Why?
|
| Cell Cycle Proteins | 2 | 2025 | 402 | 0.090 |
Why?
|
| Epigenesis, Genetic | 2 | 2015 | 407 | 0.090 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 105 | 0.090 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2015 | 422 | 0.090 |
Why?
|
| HeLa Cells | 2 | 2025 | 541 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 730 | 0.080 |
Why?
|
| Nucleosomes | 1 | 2012 | 190 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 297 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2022 | 2188 | 0.080 |
Why?
|
| Population Dynamics | 1 | 2008 | 21 | 0.070 |
Why?
|
| Binding Sites | 1 | 2010 | 921 | 0.070 |
Why?
|
| Neoplasms | 1 | 2018 | 1368 | 0.070 |
Why?
|
| DNA | 1 | 2012 | 858 | 0.070 |
Why?
|
| Mice | 4 | 2025 | 11119 | 0.060 |
Why?
|
| Asthma | 1 | 2012 | 483 | 0.060 |
Why?
|
| Phylogeny | 1 | 2008 | 388 | 0.060 |
Why?
|
| Alagille Syndrome | 1 | 2006 | 2 | 0.060 |
Why?
|
| Receptor, Notch2 | 1 | 2006 | 8 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 213 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2012 | 713 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2025 | 37 | 0.060 |
Why?
|
| 5' Untranslated Regions | 1 | 2025 | 28 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2025 | 3153 | 0.060 |
Why?
|
| Yersinia Infections | 1 | 2025 | 10 | 0.060 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 38 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2018 | 125 | 0.060 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2025 | 76 | 0.050 |
Why?
|
| Disease Resistance | 1 | 2025 | 27 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2025 | 257 | 0.050 |
Why?
|
| Single-Cell Analysis | 1 | 2025 | 116 | 0.050 |
Why?
|
| tau Proteins | 1 | 2025 | 210 | 0.050 |
Why?
|
| Cell Death | 1 | 2025 | 289 | 0.050 |
Why?
|
| Iron-Binding Proteins | 1 | 2022 | 12 | 0.050 |
Why?
|
| CCCTC-Binding Factor | 1 | 2022 | 41 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 2 | 2014 | 67 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 151 | 0.040 |
Why?
|
| Principal Component Analysis | 2 | 2014 | 65 | 0.040 |
Why?
|
| Software | 2 | 2018 | 400 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 482 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2025 | 2157 | 0.040 |
Why?
|
| Genotype | 2 | 2012 | 673 | 0.040 |
Why?
|
| Macrophages | 1 | 2025 | 1038 | 0.040 |
Why?
|
| Haplotypes | 2 | 2009 | 134 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2018 | 33 | 0.030 |
Why?
|
| Datasets as Topic | 1 | 2018 | 29 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 3485 | 0.030 |
Why?
|
| Histones | 2 | 2011 | 494 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 300 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2015 | 21 | 0.030 |
Why?
|
| Cytosine | 1 | 2015 | 31 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 483 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2018 | 433 | 0.030 |
Why?
|
| Epigenomics | 1 | 2015 | 62 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2018 | 630 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 219 | 0.030 |
Why?
|
| Genes | 1 | 2014 | 90 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2021 | 839 | 0.030 |
Why?
|
| Female | 4 | 2021 | 34018 | 0.020 |
Why?
|
| Micrococcal Nuclease | 1 | 2012 | 13 | 0.020 |
Why?
|
| Male | 4 | 2021 | 31047 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2012 | 260 | 0.020 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2010 | 6 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 195 | 0.020 |
Why?
|
| DNA Cleavage | 1 | 2010 | 18 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 405 | 0.020 |
Why?
|
| Data Mining | 1 | 2011 | 38 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2012 | 236 | 0.020 |
Why?
|
| Nigeria | 1 | 2010 | 11 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2010 | 30 | 0.020 |
Why?
|
| Gene Pool | 1 | 2009 | 1 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2009 | 5 | 0.020 |
Why?
|
| Senegal | 1 | 2009 | 17 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 146 | 0.020 |
Why?
|
| Philadelphia | 1 | 2009 | 24 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 165 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2009 | 129 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 122 | 0.020 |
Why?
|
| Russia | 1 | 2008 | 56 | 0.020 |
Why?
|
| Genome | 1 | 2010 | 285 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 261 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 602 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 992 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1640 | 0.010 |
Why?
|
| Pedigree | 1 | 2006 | 193 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 17358 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 18273 | 0.010 |
Why?
|